First patient at the Otto-von-Guericke Universitätsklinikum in Magdeburg, Germany

On June 21st 2018, the first patient at Universitätsklinikum Magdeburg was treated with QuiremSpheres in Magdeburg, Germany. The multidisciplinary team led by Prof. Dr. Maciej Pech (Director), PD Dr. med. Maciej Powerski (IR),  Prof. Dr. Michael Kreißl (NM physician), Dr. Oliver Großer (Physicist) and Hr. Maurice Klopfleisch (Radiopharmacist) successfully performed the SIRT procedure with QuiremSpheres to treat a patient suffering from metastatic liver cancer (mCRC). QuiremSpheres are the only commercially available SIRT solution based on the radioisotope Holmium-166. The unique properties of Holmium-166 allow physicians to perform post-procedural quantitative imaging of the microspheres to verify the particle and dose distribution.

The Universitätsklinikum Magdeburg is yet another leading SIRT center in Germany choosing QuiremSpheres in their efforts to provide best care to patients suffering from liver cancer or metastases in the liver.

Share this post

Necessary cookies help make a website more usable by enabling basic functions such as page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

Enable

Statistical cookies help us understand how visitors use the website by collecting and reporting data anonymously. These cookies therefore do not collect any personal data from visitors.

Cookies are small text files that can be used by websites to make user experiences more efficient. By law, we may store cookies on your device if they are strictly necessary for the use of the website. These are the functional cookies. We need your consent for all other types of cookies. These cookies are named as: preferences and statistics and you do not have to accept them. This website uses different types of cookies. Some cookies are placed by third party services that are displayed on our pages.

This website uses cookies to improve your experience. You can manage your options here.